📰 Key Statistics News
Page 37 - Key Statistics News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Key Statistics. Real-time updates on events, politics, business and more.
September 6, 2023
More than 37,000 alien species have been introduced by many human activities to regions and biomes around the world.
September 5, 2023
Company AnnouncementPhase 3 innovaTV 301 confirmatory trial met its primary endpoint of improved overall survival (OS) at predetermined, independent interim analysisTrial results to be submitted for presentation at a future medical meetingGenmab and Seagen to engage in discussions with regulatory authoritiesCOPENHAG...
September 4, 2023
Company Announcement Phase 3 innovaTV 301 confirmatory trial met its primary endpoint of improved overall survival at predetermined, independent interim analysisTrial results to be submitted for...
August 29, 2023
Prostate cancer is the second-leading cause of cancer death among American men. With 1 in 8 facing this diagnosis over his lifetime, according to the American Cancer Society, curiosity about
August 16, 2023
Study Reveals LEMS Often Goes Undiagnosed in U.S. Patients with Small Cell Lung Cancer...
August 16, 2023
CORAL GABLES, Fla., Aug. 16, 2023 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. ("Catalyst") (Nasdaq: CPRX), a commercial-stage, patient-centric biopharmaceutical company focused on in-licensing, developing, and commercializing novel high-quality medicines for
August 16, 2023
Study Reveals LEMS Often Goes Undiagnosed in U.S. Patients with Small Cell Lung CancerCORAL GABLES, Fla., Aug. 16, 2023 -- Catalyst Pharmaceuticals, Inc. , a commercial-stage, patient-centric... -Today at 10:57 am- MarketScreener
August 15, 2023
Airline Technology Integration Market Size Predictions Suggest a Rise of 13.7% CAGR to Reach a Value of USD 76.4 Billion by 2032
August 14, 2023
MONTHLY FACTSHEET • 31 JULY 2023 Monthly Factsheet HOW WE INVEST ... -Today at 08:09 am- MarketScreener
August 9, 2023
Daiichi Sankyo today announced that VANFLYTA® is now available by prescription in the U.S. VANFLYTA is the first and only FLT3 inhibitor to be approved by the U.S. Food and Drug Administration ...